<DOC>
	<DOCNO>NCT00435799</DOCNO>
	<brief_summary>The purpose study assess safety , efficacy stability riboflavin-UV induce cross-linking corneal collagen reduce progression keratecatasia improve visual acuity . This first Norwegian study concern CCL .</brief_summary>
	<brief_title>Evaluating Collagen Cross-Linking ( CCL ) Treatment Norway</brief_title>
	<detailed_description>The technique corneal collagen cross-linking consist photopolymerization stromal fiber combine action photosensitize substance , riboflavin ultraviolet type A ray ( UVA ) solid-state UVA Source . Photopolymerization increase rigidity corneal collagen resistance keratectasia . It use stop progression keratectasia . Corneal transplantation available option far treatment keratectasia advance stage Norway . The method CCL use riboflavin UV light technically simple much less invasive corneal transplantation treat prevents underlie pathophysiological mechanism . It also reduce chance successful corneal transplantation , case would still necessary CCL . The purpose study assess safety , efficacy stability riboflavin-UV induce cross-linking corneal collagen reduce progression keratecatasia improve visual acuity . This first Norwegian study concern CCL .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>1 . Age 20 45 year 2 . Progressive keratectasia ( primary secondary ) advance stage 3 . Decreased best correct visual acuity bellow 20/40 , improve use soft contact lenses 4 . Rigid contact lenses either tolerate improve visual acuity 5 . No previous eye surgery ( except laser refractive surgery ) 6 . All patient must provide write informed consent become study subject 7 . Subjects able return schedule followup examination accord protocol 1 . Corneal thickness &lt; 400 Âµm thin position 2 . Keratometric read 60 diopter 3 . Other active ocular disease keratectasia 4 . Herpes keratitis 5 . Previous ocular surgery ( laser refractive surgery ) 6 . Patients immunocompromised , pregnant atopic syndrome , connective tissue autoimmune disease 7 . Patients know sensitivity study medication 8 . Subjects intraocular pressure &gt; 23 mmHg Goldmann applanation tonometry , history glaucoma , glaucoma suspect 9 . Subjects intent participate ophthalmic clinical trail clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>keratoconus</keyword>
	<keyword>corneal cross-linking</keyword>
	<keyword>riboflavine</keyword>
	<keyword>ultraviolet type A ray ( UVA )</keyword>
</DOC>